ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway

Table 1 Correlation of ARHGAP10 expression with NSCLC clinicopathological characteristics

Characteristics	No. of patients	ARHGAP10 expression		p value
Characteristics	No. of patients	Negative	Positive	p value
Age
≥ 60	34	14	20	0.621
< 60	32	16	16	0.621
Gender
Male	39	15	24	0.213
Female	27	15	12	0.213
Histological type
LUAD	50	26	24	0.084
LUSC	16	4	12	0.084
Lymphnode metastasis
Absent	42	15	27	0.043*
Present	24	15	9	0.043*
TNM stage
I + II	51	19	32	0.019*
III + IV	15	11	4	0.019*

ISSN: 1475-2867